Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials

BACKGROUND: Preliminary placebo-controlled evidence paved the ground to the US Food and Drug Administration approval extension of lisdexamfetamine for the treatment of moderate-to-severe binge eating disorder (BED) in adults. OBJECTIVES: To provide a preliminary qualitative and quantitative synthesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornaro, Michele, Solmi, Marco, Perna, Giampaolo, De Berardis, Domenico, Veronese, Nicola, Orsolini, Laura, Ganança, Licinia, Stubbs, Brendon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966690/
https://www.ncbi.nlm.nih.gov/pubmed/27524900
http://dx.doi.org/10.2147/NDT.S109637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966690/
https://www.ncbi.nlm.nih.gov/pubmed/27524900
http://dx.doi.org/10.2147/NDT.S109637

Ejemplares similares